Fig. 8: Incremental SOCS2 promoted ubiquitination degradation of SLC7A11 and induced ferroptosis and radiosensitization of HCC. | Cell Death & Differentiation

Fig. 8: Incremental SOCS2 promoted ubiquitination degradation of SLC7A11 and induced ferroptosis and radiosensitization of HCC.

From: SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma

Fig. 8: Incremental SOCS2 promoted ubiquitination degradation of SLC7A11 and induced ferroptosis and radiosensitization of HCC.The alternative text for this image may have been generated using AI.

A The pathway of SOCS2 sensitization. After IR, a rapid increase of SOCS2 led to a decrease of SLC7A11 and advanced ferroptosis and radiosensitization. B Diagram of the specific mechanism of SOCS2-induced ferroptosis. SOCS2-SH2 recognized SLC7A11-NTD, bound ubiquitin molecules which was linked to E2 ubiquitin-binding enzymes with the joint involvement of elongin B (EB) and elongin C (EC), and facilitated the transfer of ubiquitin molecules to the substrate protein SLC7A11 to promote SLC7A11 degradation. This degradation subsequently caused a reduction in cystine intake as well as a reduction in GSH and GPX4 and ultimately advanced ferroptosis. C The processes of SLC7A11 protein ubiquitination. In an ATP-dependent reaction, Ub was attached to the ubiquitin-activating enzyme E1 and activated, then delivered to the ubiquitin-binding enzyme E2. Next, the E3 ligase SOCS2 acted as a bridge, identifying E2-Ub and the substrate SLC7A11 to facilitate the association of Ub with SLC7A11. After several repetitions of the above process, a K48-ubiquitin chain was formed and attached to SLC7A11. Finally, the K48-ubiquitin chain was identified by the 26 S proteasome, leading to the degradation of SLC7A11 to fragments. Yellow arrows indicate the experimental results argued in this paper while black arrows represent results reported in other literature.

Back to article page